Health-related quality of life in survivors of severe COVID-19 infection.
Gabriele d'EttorrePaolo VassaliniVincenzo CoppolelliElio Gentilini CacciolaLetizia SanitinelliLuca MaddaloniSilvia FabrisClaudio M MastroianniGabriella d'EttorreGiancarlo CeccarelliPublished in: Pharmacological reports : PR (2022)
HRQoL showed to be still low in patients 2 years after acute severe COVID-19. Given the significant impact of SARS-CoV-2 on long-term chronic symptoms, predictors of poor outcomes must be considered during the acute phase of illness to plan a tailored follow-up path for each patient.
Keyphrases
- sars cov
- end stage renal disease
- coronavirus disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- early onset
- respiratory syndrome coronavirus
- case report
- young adults
- drug induced
- patient reported outcomes
- type diabetes
- metabolic syndrome
- smoking cessation
- depressive symptoms
- patient reported
- glycemic control